Market Currents
Sanofi (SNY +4.8%) is higher today after the FDA approves Zaltrap, a drug developed by SNY and...
-
Friday, August 3, 2012, 2:36 PM ETSanofi (SNY +4.8%) is higher today after the FDA approves Zaltrap, a drug developed by SNY and Regeneron Pharmaceuticals (REGN +1%) for the treatment of advanced colon cancer.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
